These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26705579)

  • 21. Economic burden of postoperative ileus associated with colectomy in the United States.
    Iyer S; Saunders WB; Stemkowski S
    J Manag Care Pharm; 2009; 15(6):485-94. PubMed ID: 19610681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery.
    Gillespie EL; White CM; Kluger J; Rancourt JA; Gallagher R; Coleman CI
    Pharmacotherapy; 2006 Apr; 26(4):499-504. PubMed ID: 16553508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis.
    Mercaldi CJ; Lanes SF
    Chest; 2013 Feb; 143(2):532-538. PubMed ID: 23381318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with atrial fibrillation undergoing total joint arthroplasty increase hospital burden.
    Aggarwal VK; Tischler EH; Post ZD; Kane I; Orozco FR; Ong A
    J Bone Joint Surg Am; 2013 Sep; 95(17):1606-11. PubMed ID: 24005202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.
    Olesen JB; Lip GY; Hansen PR; Lindhardsen J; Ahlehoff O; Andersson C; Weeke P; Hansen ML; Gislason GH; Torp-Pedersen C
    J Thromb Haemost; 2011 Aug; 9(8):1460-7. PubMed ID: 21624047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.
    Kim MH; Klingman D; Lin J; Pathak P; Battleman DS
    Ann Pharmacother; 2009 May; 43(5):840-8. PubMed ID: 19417111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital cost and length of stay in idiopathic pulmonary fibrosis.
    Mooney JJ; Raimundo K; Chang E; Broder MS
    J Med Econ; 2017 May; 20(5):518-524. PubMed ID: 28092235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants.
    Fermann GJ; Lovelace B; Christoph MJ; Lingohr-Smith M; Lin J; Deitelzweig SB
    J Med Econ; 2020 Dec; 23(12):1409-1417. PubMed ID: 33054507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalization expenses of acute ischemic stroke patients with atrial fibrillation relative to those with normal sinus rhythm.
    Li J; Luo W
    J Med Econ; 2017 Feb; 20(2):114-120. PubMed ID: 27559816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of colonoscopy and outcomes in patients with lower GI bleeding: a nationwide population-based study.
    Navaneethan U; Njei B; Venkatesh PG; Sanaka MR
    Gastrointest Endosc; 2014 Feb; 79(2):297-306.e12. PubMed ID: 24060518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future.
    Sheikh A; Patel NJ; Nalluri N; Agnihotri K; Spagnola J; Patel A; Asti D; Kanotra R; Khan H; Savani C; Arora S; Patel N; Thakkar B; Patel N; Pau D; Badheka AO; Deshmukh A; Kowalski M; Viles-Gonzalez J; Paydak H
    Prog Cardiovasc Dis; 2015; 58(2):105-16. PubMed ID: 26162957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of atrial fibrillation on the hospital sector in Canada.
    O'Reilly DJ; Hopkins RB; Healey JS; Dorian P; Sauriol L; Tarride JE; Burke N; Goeree RA
    Can J Cardiol; 2013 Feb; 29(2):229-35. PubMed ID: 22652091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does warfarin use impact hospital length of stay? A retrospective study looking at patients treated for atrial fibrillation.
    Mittmann N; Henry B; Murshed S; Tsang L; Iazzetta J; Crystal E; Bucci C
    Hosp Top; 2013; 91(1):20-4. PubMed ID: 23428112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
    Berry EA; Heaton PT; Kelton CM
    J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
    Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
    Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
    Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a mass casualty incident: clinical outcomes and hospital charges for casualty patients versus concurrent inpatients.
    Abir M; Choi H; Cooke CR; Wang SC; Davis MM
    Acad Emerg Med; 2012 Mar; 19(3):280-6. PubMed ID: 22435860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
    Dasta JF; Chiong JR; Christian R; Lin J
    Hosp Pract (1995); 2012 Feb; 40(1):7-14. PubMed ID: 22406878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.